Akeega (Niraparib and Abiraterone Acetate) for Prostate Cancer
Overview Akeega is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) who have a BRCA mutation (a change in BRCA1 or BRCA2…